Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22867032 | 0.99 | NLRP3 (0.64) | NLRP3LIPG | |
| Potassium SCHEMBL30957790 | 0.92 | NLRP3 (0.63) | NLRP3 | |
| SCHEMBL22867163 | 0.91 | NLRP3 (0.64) | NLRP3 | |
| SCHEMBL22866873 | 0.90 | NLRP3 (0.63) | NLRP3LIPG | |
| SCHEMBL22867030 | 0.89 | NLRP3 (0.62) | NLRP3 | |
| SCHEMBL22867096 | 0.89 | NLRP3 (0.62) | NLRP3 | |
| Potassium SCHEMBL30957789 | 0.87 | NLRP3 (0.63) | NLRP3 | |
| SCHEMBL22867147 | 0.87 | NLRP3 (0.64) | NLRP3 | |
| SCHEMBL22867031 | 0.86 | NLRP3 (0.59) | NLRP3 | |
| SCHEMBL30957780 | 0.86 | NLRP3 (0.59) | NLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030879-B2 | Sulfonyl acetamides as NLRP3 inhibitors | INFLAZOME LIMITED (IE) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030879-B2 | Sulfonyl acetamides as NLRP3 inhibitors | NLRP3, NOD1, NLRP1 | NLRP3 1/4885LIPG 3751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.